{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T12:52:44Z","timestamp":1755694364267},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,12,3]],"date-time":"2015-12-03T00:00:00Z","timestamp":1449100800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"KAKENHI","award":["21590512, 24590556, and 15K09345"],"award-info":[{"award-number":["21590512, 24590556, and 15K09345"]}]},{"name":"Health and Labor Sciences Research Grants","award":["H22-013, H23-126, H25-023, and H25-028"],"award-info":[{"award-number":["H22-013, H23-126, H25-023, and H25-028"]}]},{"name":"the Japan Agency for Medical Research and Development (AMED)"},{"name":"the Project of Establishing Medical Research Base Networks against Infectious Diseases in Okinawa"},{"name":"the Novartis Foundation for the Promotion of Science (Japan)"},{"name":"the Joint Usage\/Research Center Program of the Institute for Virus Research, Kyoto University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Neurovirol."],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s13365-015-0407-2","type":"journal-article","created":{"date-parts":[[2015,12,3]],"date-time":"2015-12-03T14:08:56Z","timestamp":1449151736000},"page":"416-430","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["HTLV-1 subgroups associated with the risk of HAM\/TSP are related to viral and host gene expression in peripheral blood mononuclear cells, independent of the transactivation functions of the viral factors"],"prefix":"10.1007","volume":"22","author":[{"given":"Keiko","family":"Yasuma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Matsuzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihisa","family":"Yamano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Takashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mineki","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,3]]},"reference":[{"key":"407_CR1","doi-asserted-by":"crossref","first-page":"9828","DOI":"10.1128\/JVI.74.21.9828-9835.2000","volume":"74","author":"B Albrecht","year":"2000","unstructured":"Albrecht B, Collins ND, Burniston MT, Nisbet JW, Ratner L, Green PL, Lairmore MD (2000) Human T-lymphotropic virus type 1 open reading frame I p12(I) is required for efficient viral infectivity in primary lymphocytes. J Virol 74:9828\u201335","journal-title":"J Virol"},{"key":"407_CR2","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s11481-014-9547-z","volume":"9","author":"MR Anderson","year":"2014","unstructured":"Anderson MR, Enose-Akahata Y, Massoud R, Ngouth N, Tanaka Y, Oh U, Jacobson S (2014) Epigenetic modification of the FoxP3 TSDR in HAM\/TSP decreases the functional suppression of Tregs. J Neuroimmune Pharmacol 9:522\u201332","journal-title":"J Neuroimmune Pharmacol"},{"key":"407_CR3","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1182\/blood-2001-12-0372","volume":"100","author":"B Arnulf","year":"2002","unstructured":"Arnulf B, Villemain A, Nicot C, Mordelet E, Charneau P, Kersual J, Zermati Y, Mauviel A, Bazarbachi A, Hermine O (2002) Human T-cell lymphotropic virus oncoprotein Tax represses TGF-beta 1 signaling in human T cells via c-Jun activation: a potential mechanism of HTLV-I leukemogenesis. Blood 100:4129\u201338","journal-title":"Blood"},{"key":"407_CR4","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1128\/JVI.61.7.2175-2181.1987","volume":"61","author":"J Brady","year":"1987","unstructured":"Brady J, Jeang KT, Duvall J, Khoury G (1987) Identification of p40x-responsive regulatory sequences within the human T-cell leukemia virus type I long terminal repeat. J Virol 61:2175\u201381","journal-title":"J Virol"},{"key":"407_CR5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1742-4690-3-15","volume":"3","author":"MH Cavanagh","year":"2006","unstructured":"Cavanagh MH, Landry S, Audet B, Arpin-Andre C, Hivin P, Pare ME, Thete J, Wattel E, Marriott SJ, Mesnard JM, Barbeau B (2006) HTLV-I antisense transcripts initiating in the 3\u2032LTR are alternatively spliced and polyadenylated. Retrovirology 3:15","journal-title":"Retrovirology"},{"key":"407_CR6","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/aid.1993.9.381","volume":"9","author":"G The de","year":"1993","unstructured":"de The G, Bomford R (1993) An HTLV-I vaccine: why, how, for whom? AIDS Res Hum Retrovir 9:381\u20136","journal-title":"AIDS Res Hum Retrovir"},{"key":"407_CR7","doi-asserted-by":"crossref","first-page":"7278","DOI":"10.1128\/JVI.02239-09","volume":"84","author":"J Fan","year":"2010","unstructured":"Fan J, Ma G, Nosaka K, Tanabe J, Satou Y, Koito A, Wain-Hobson S, Vartanian JP, Matsuoka M (2010) APOBEC3G generates nonsense mutations in human T-cell leukemia virus type 1 proviral genomes in vivo. J Virol 84:7278\u201387","journal-title":"J Virol"},{"key":"407_CR8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3109\/13550289709015789","volume":"3","author":"W Fu","year":"1997","unstructured":"Fu W, Shah SR, Jiang H, Hilt DC, Dave HP, Joshi JB (1997) Transactivation of proenkephalin gene by HTLV-1 tax1 protein in glial cells: involvement of Fos\/Jun complex at an AP-1 element in the proenkephalin gene promoter. J Neurovirol 3:16\u201327","journal-title":"J Neurovirol"},{"key":"407_CR9","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1128\/JVI.63.8.3234-3239.1989","volume":"63","author":"J Fujisawa","year":"1989","unstructured":"Fujisawa J, Toita M, Yoshida M (1989) A unique enhancer element for the trans activator (p40tax) of human T-cell leukemia virus type I that is distinct from cyclic AMP- and 12-O-tetradecanoylphorbol-13-acetate-responsive elements. J Virol 63:3234\u20139","journal-title":"J Virol"},{"key":"407_CR10","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1086\/315897","volume":"182","author":"Y Furukawa","year":"2000","unstructured":"Furukawa Y, Yamashita M, Usuku K, Izumo S, Nakagawa M, Osame M (2000) Phylogenetic subgroups of human T cell lymphotropic virus (HTLV) type I in the tax gene and their association with different risks for HTLV-I-associated myelopathy\/tropical spastic paraparesis. J Infect Dis 182:1343\u20139","journal-title":"J Infect Dis"},{"key":"407_CR11","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(85)92734-5","volume":"2","author":"A Gessain","year":"1985","unstructured":"Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, de The G (1985) Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2:407\u201310","journal-title":"Lancet"},{"key":"407_CR12","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1080\/13550280802178538","volume":"14","author":"D Hayashi","year":"2008","unstructured":"Hayashi D, Kubota R, Takenouchi N, Nakamura T, Umehara F, Arimura K, Izumo S, Osame M (2008) Accumulation of human T-lymphotropic virus type I (HTLV-I)-infected cells in the cerebrospinal fluid during the exacerbation of HTLV-I-associated myelopathy. J Neurovirol 14:459\u201363","journal-title":"J Neurovirol"},{"key":"407_CR13","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1086\/424598","volume":"190","author":"M Hisada","year":"2004","unstructured":"Hisada M, Stuver SO, Okayama A, Li HC, Sawada T, Hanchard B, Mueller NE (2004) Persistent paradox of natural history of human T lymphotropic virus type I: parallel analyses of Japanese and Jamaican carriers. J Infect Dis 190:1605\u20139","journal-title":"J Infect Dis"},{"key":"407_CR14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nri2474","volume":"9","author":"J Huehn","year":"2009","unstructured":"Huehn J, Polansky JK, Hamann A (2009) Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage? Nat Rev Immunol 9:83\u20139","journal-title":"Nat Rev Immunol"},{"key":"407_CR15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1006\/viro.2000.0669","volume":"279","author":"K Iwai","year":"2001","unstructured":"Iwai K, Mori N, Oie M, Yamamoto N, Fujii M (2001) Human T-cell leukemia virus type 1 tax protein activates transcription through AP-1 site by inducing DNA binding activity in T cells. Virology 279:38\u201346","journal-title":"Virology"},{"key":"407_CR16","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1212\/WNL.46.4.1016","volume":"46","author":"S Izumo","year":"1996","unstructured":"Izumo S, Goto I, Itoyama Y, Okajima T, Watanabe S, Kuroda Y, Araki S, Mori M, Nagataki S, Matsukura S, Akamine T, Nakagawa M, Yamamoto I, Osame M (1996) Interferon-alpha is effective in HTLV-I-associated myelopathy: a multicenter, randomized, double-blind, controlled trial. Neurology 46:1016\u201321","journal-title":"Neurology"},{"key":"407_CR17","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1086\/431514","volume":"192","author":"GC John-Stewart","year":"2005","unstructured":"John-Stewart GC, Nduati RW, Rousseau CM, Mbori-Ngacha DA, Richardson BA, Rainwater S, Panteleeff DD, Overbaugh J (2005) Subtype C is associated with increased vaginal shedding of HIV-1. J Infect Dis 192:492\u20136","journal-title":"J Infect Dis"},{"key":"407_CR18","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/QAD.0b013e328326f77f","volume":"23","author":"M Keller","year":"2009","unstructured":"Keller M, Lu Y, Lalonde RG, Klein MB (2009) Impact of HIV-1 viral subtype on CD4+ T-cell decline and clinical outcomes in antiretroviral naive patients receiving universal healthcare. AIDS 23:731\u20137","journal-title":"AIDS"},{"key":"407_CR19","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1097\/QAD.0b013e328330cc08","volume":"23","author":"N Kiwanuka","year":"2009","unstructured":"Kiwanuka N, Laeyendecker O, Quinn TC, Wawer MJ, Shepherd J, Robb M, Kigozi G, Kagaayi J, Serwadda D, Makumbi FE, Reynolds SJ, Gray RH (2009) HIV-1 subtypes and differences in heterosexual HIV transmission among HIV-discordant couples in Rakai, Uganda. AIDS 23:2479\u201384","journal-title":"AIDS"},{"key":"407_CR20","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/QAI.0b013e3181c98fc0","volume":"54","author":"N Kiwanuka","year":"2010","unstructured":"Kiwanuka N, Robb M, Laeyendecker O, Kigozi G, Wabwire-Mangen F, Makumbi FE, Nalugoda F, Kagaayi J, Eller M, Eller LA, Serwadda D, Sewankambo NK, Reynolds SJ, Quinn TC, Gray RH, Wawer MJ, Whalen CC (2010) HIV-1 viral subtype differences in the rate of CD4+ T-cell decline among HIV seroincident antiretroviral naive persons in Rakai district, Uganda. J Acquir Immune Defic Syndr 54:180\u20134","journal-title":"J Acquir Immune Defic Syndr"},{"key":"407_CR21","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/jama.2014.7085","volume":"312","author":"A Kohli","year":"2014","unstructured":"Kohli A, Shaffer A, Sherman A, Kottilil S (2014) Treatment of hepatitis C: a systematic review. JAMA 312:631\u201340","journal-title":"JAMA"},{"key":"407_CR22","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/oxfordjournals.aje.a117580","volume":"142","author":"A Kramer","year":"1995","unstructured":"Kramer A, Maloney EM, Morgan OS, Rodgers-Johnson P, Manns A, Murphy EL, Larsen S, Cranston B, Murphy J, Benichou J et al (1995) Risk factors and cofactors for human T-cell lymphotropic virus type I (HTLV-I)-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) in Jamaica. Am J Epidemiol 142:1212\u201320","journal-title":"Am J Epidemiol"},{"key":"407_CR23","doi-asserted-by":"crossref","first-page":"361","DOI":"10.4049\/jimmunol.1100070","volume":"187","author":"CW Kuo","year":"2011","unstructured":"Kuo CW, Mirsaliotis A, Brighty DW (2011) Antibodies to the envelope glycoprotein of human T cell leukemia virus type 1 robustly activate cell-mediated cytotoxic responses and directly neutralize viral infectivity at multiple steps of the entry process. J Immunol 187:361\u201371","journal-title":"J Immunol"},{"key":"407_CR24","doi-asserted-by":"crossref","first-page":"33766","DOI":"10.1074\/jbc.M200150200","volume":"277","author":"DK Lee","year":"2002","unstructured":"Lee DK, Kim BC, Brady JN, Jeang KT, Kim SJ (2002) Human T-cell lymphotropic virus type 1 tax inhibits transforming growth factor-beta signaling by blocking the association of Smad proteins with Smad-binding element. J Biol Chem 277:33766\u201375","journal-title":"J Biol Chem"},{"key":"407_CR25","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1038\/onc.2012.450","volume":"32","author":"G Ma","year":"2013","unstructured":"Ma G, Yasunaga J, Fan J, Yanagawa S, Matsuoka M (2013) HTLV-1 bZIP factor dysregulates the Wnt pathways to support proliferation and migration of adult T-cell leukemia cells. Oncogene 32:4222\u201330","journal-title":"Oncogene"},{"key":"407_CR26","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1128\/JVI.02686-14","volume":"89","author":"Y Maeda","year":"2015","unstructured":"Maeda Y, Terasawa H, Tanaka Y, Mitsuura C, Nakashima K, Yusa K, Harada S (2015) Separate cellular localizations of human T-lymphotropic virus 1 (HTLV-1) Env and glucose transporter type 1 (GLUT1) are required for HTLV-1 Env-mediated fusion and infection. J Virol 89:502\u201311","journal-title":"J Virol"},{"key":"407_CR27","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.2741\/1474","volume":"9","author":"N Manel","year":"2004","unstructured":"Manel N, Taylor N, Kinet S, Kim FJ, Swainson L, Lavanya M, Battini JL, Sitbon M (2004) HTLV envelopes and their receptor GLUT1, the ubiquitous glucose transporter: a new vision on HTLV infection? Front Biosci 9:3218\u201341","journal-title":"Front Biosci"},{"key":"407_CR28","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/sj.onc.1208297","volume":"24","author":"J Matsumoto","year":"2005","unstructured":"Matsumoto J, Ohshima T, Isono O, Shimotohno K (2005) HTLV-1 HBZ suppresses AP-1 activity by impairing both the DNA-binding ability and the stability of c-Jun protein. Oncogene 24:1001\u201310","journal-title":"Oncogene"},{"key":"407_CR29","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.mam.2010.06.002","volume":"31","author":"M Matsuoka","year":"2010","unstructured":"Matsuoka M (2010) HTLV-1 bZIP factor gene: its roles in HTLV-1 pathogenesis. Mol Asp Med 31:359\u201366","journal-title":"Mol Asp Med"},{"key":"407_CR30","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/intimm\/dxu048","volume":"26","author":"P Miyazato","year":"2014","unstructured":"Miyazato P, Matsuoka M (2014) Human T-cell leukemia virus type 1 and Foxp3 expression: viral strategy in vivo. Int Immunol 26:419\u2013425","journal-title":"Int Immunol"},{"key":"407_CR31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.humimm.2004.05.016","volume":"66","author":"ME Morgan","year":"2005","unstructured":"Morgan ME, van Bilsen JH, Bakker AM, Heemskerk B, Schilham MW, Hartgers FC, Elferink BG, van der Zanden L, de Vries RR, Huizinga TW, Ottenhoff TH, Toes RE (2005) Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans. Hum Immunol 66:13\u201320","journal-title":"Hum Immunol"},{"key":"407_CR32","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1128\/JVI.80.5.2495-2505.2006","volume":"80","author":"K Murata","year":"2006","unstructured":"Murata K, Hayashibara T, Sugahara K, Uemura A, Yamaguchi T, Harasawa H, Hasegawa H, Tsuruda K, Okazaki T, Koji T, Miyanishi T, Yamada Y, Kamihira S (2006) A novel alternative splicing isoform of human T-cell leukemia virus type 1 bZIP factor (HBZ-SI) targets distinct subnuclear localization. J Virol 80:2495\u2013505","journal-title":"J Virol"},{"key":"407_CR33","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3109\/13550289809114225","volume":"4","author":"M Nagai","year":"1998","unstructured":"Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi N, Moritoyo T, Hashiguchi S, Ichinose M, Bangham CR, Izumo S, Osame M (1998) Analysis of HTLV-I proviral load in 202 HAM\/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM\/TSP. J Neurovirol 4:586\u201393","journal-title":"J Neurovirol"},{"key":"407_CR34","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3109\/13550289509111010","volume":"1","author":"M Nakagawa","year":"1995","unstructured":"Nakagawa M, Izumo S, Ijichi S, Kubota H, Arimura K, Kawabata M, Osame M (1995) HTLV-I-associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings. J Neurovirol 1:50\u201361","journal-title":"J Neurovirol"},{"key":"407_CR35","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1182\/blood.V98.3.823","volume":"98","author":"C Nicot","year":"2001","unstructured":"Nicot C, Mulloy JC, Ferrari MG, Johnson JM, Fu K, Fukumoto R, Trovato R, Fullen J, Leonard WJ, Franchini G (2001) HTLV-1 p12(I) protein enhances STAT5 activation and decreases the interleukin-2 requirement for proliferation of primary human peripheral blood mononuclear cells. Blood 98:823\u20139","journal-title":"Blood"},{"key":"407_CR36","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nm984","volume":"10","author":"C Nicot","year":"2004","unstructured":"Nicot C, Dundr M, Johnson JM, Fullen JR, Alonzo N, Fukumoto R, Princler GL, Derse D, Misteli T, Franchini G (2004) HTLV-1-encoded p30II is a post-transcriptional negative regulator of viral replication. Nat Med 10:197\u2013201","journal-title":"Nat Med"},{"key":"407_CR37","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.4049\/jimmunol.1301843","volume":"191","author":"SA Oh","year":"2013","unstructured":"Oh SA, Li MO (2013) TGF-beta: guardian of T cell function. J Immunol 191:3973\u20139","journal-title":"J Immunol"},{"key":"407_CR38","volume-title":"Review of WHO Kagoshima meeting and diagnostic guidelines for HAM\/TSP","author":"M Osame","year":"1990","unstructured":"Osame M (1990) Review of WHO Kagoshima meeting and diagnostic guidelines for HAM\/TSP. Raven, New York"},{"key":"407_CR39","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0140-6736(86)91298-5","volume":"1","author":"M Osame","year":"1986","unstructured":"Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M (1986) HTLV-I associated myelopathy, a new clinical entity. Lancet 1:1031\u20132","journal-title":"Lancet"},{"key":"407_CR40","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/ana.410280110","volume":"28","author":"M Osame","year":"1990","unstructured":"Osame M, Janssen R, Kubota H, Nishitani H, Igata A, Nagataki S, Mori M, Goto I, Shimabukuro H, Khabbaz R et al (1990) Nationwide survey of HTLV-I-associated myelopathy in Japan: association with blood transfusion. Ann Neurol 28:50\u20136","journal-title":"Ann Neurol"},{"key":"407_CR41","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1038\/sj.onc.1208968","volume":"24","author":"FA Proietti","year":"2005","unstructured":"Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL (2005) Global epidemiology of HTLV-I infection and associated diseases. Oncogene 24:6058\u201368","journal-title":"Oncogene"},{"key":"407_CR42","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1099\/vir.0.80509-0","volume":"86","author":"AH Sabouri","year":"2005","unstructured":"Sabouri AH, Saito M, Usuku K, Bajestan SN, Mahmoudi M, Forughipour M, Sabouri Z, Abbaspour Z, Goharjoo ME, Khayami E, Hasani A, Izumo S, Arimura K, Farid R, Osame M (2005) Differences in viral and host genetic risk factors for development of human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy\/tropical spastic paraparesis between Iranian and Japanese HTLV-1-infected individuals. J Gen Virol 86:773\u201381","journal-title":"J Gen Virol"},{"key":"407_CR43","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1086\/380101","volume":"189","author":"M Saito","year":"2004","unstructured":"Saito M, Nakagawa M, Kaseda S, Matsuzaki T, Jonosono M, Eiraku N, Kubota R, Takenouchi N, Nagai M, Furukawa Y, Usuku K, Izumo S, Osame M (2004) Decreased human T lymphotropic virus type I (HTLV-I) provirus load and alteration in T cell phenotype after interferon-alpha therapy for HTLV-I-associated myelopathy\/tropical spastic paraparesis. J Infect Dis 189:29\u201340","journal-title":"J Infect Dis"},{"key":"407_CR44","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1742-4690-6-19","volume":"6","author":"M Saito","year":"2009","unstructured":"Saito M, Matsuzaki T, Satou Y, Yasunaga J, Saito K, Arimura K, Matsuoka M, Ohara Y (2009) In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy\/tropical spastic paraparesis (HAM\/TSP). Retrovirology 6:19","journal-title":"Retrovirology"},{"key":"407_CR45","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1073\/pnas.0507631103","volume":"103","author":"Y Satou","year":"2006","unstructured":"Satou Y, Yasunaga J, Yoshida M, Matsuoka M (2006) HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. Proc Natl Acad Sci U S A 103:720\u20135","journal-title":"Proc Natl Acad Sci U S A"},{"key":"407_CR46","doi-asserted-by":"crossref","first-page":"e1001274","DOI":"10.1371\/journal.ppat.1001274","volume":"7","author":"Y Satou","year":"2011","unstructured":"Satou Y, Yasunaga J, Zhao T, Yoshida M, Miyazato P, Takai K, Shimizu K, Ohshima K, Green PL, Ohkura N, Yamaguchi T, Ono M, Sakaguchi S, Matsuoka M (2011) HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo. PLoS Pathog 7:e1001274","journal-title":"PLoS Pathog"},{"key":"407_CR47","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1073\/pnas.80.12.3618","volume":"80","author":"M Seiki","year":"1983","unstructured":"Seiki M, Hattori S, Hirayama Y, Yoshida M (1983) Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc Natl Acad Sci U S A 80:3618\u201322","journal-title":"Proc Natl Acad Sci U S A"},{"key":"407_CR48","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1182\/blood-2011-05-357459","volume":"119","author":"K Sugata","year":"2012","unstructured":"Sugata K, Satou Y, Yasunaga J, Hara H, Ohshima K, Utsunomiya A, Mitsuyama M, Matsuoka M (2012) HTLV-1 bZIP factor impairs cell-mediated immunity by suppressing production of Th1 cytokines. Blood 119:434\u201344","journal-title":"Blood"},{"key":"407_CR49","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/ijc.2910450206","volume":"45","author":"K Tajima","year":"1990","unstructured":"Tajima K (1990) The 4th nation-wide study of adult T-cell leukemia\/lymphoma (ATL) in Japan: estimates of risk of ATL and its geographical and clinical features. The T- and B-cell Malignancy Study Group. Int J Cancer 45:237\u201343","journal-title":"Int J Cancer"},{"key":"407_CR50","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0092-8674(90)90589-7","volume":"60","author":"M Tanaka","year":"1990","unstructured":"Tanaka M, Herr W (1990) Differential transcriptional activation by Oct-1 and Oct-2: interdependent activation domains induce Oct-2 phosphorylation. Cell 60:375\u201386","journal-title":"Cell"},{"key":"407_CR51","doi-asserted-by":"crossref","first-page":"11467","DOI":"10.1128\/JVI.00952-09","volume":"83","author":"JM Taylor","year":"2009","unstructured":"Taylor JM, Brown M, Nejmeddine M, Kim KJ, Ratner L, Lairmore M, Nicot C (2009) Novel role for interleukin-2 receptor-Jak signaling in retrovirus transmission. J Virol 83:11467\u201376","journal-title":"J Virol"},{"key":"407_CR52","doi-asserted-by":"crossref","first-page":"7018","DOI":"10.1038\/onc.2008.351","volume":"27","author":"M Thomas","year":"2008","unstructured":"Thomas M, Narayan N, Pim D, Tomaic V, Massimi P, Nagasaka K, Kranjec C, Gammoh N, Banks L (2008) Human papillomaviruses, cervical cancer and cell polarity. Oncogene 27:7018\u201330","journal-title":"Oncogene"},{"key":"407_CR53","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/ni1549","volume":"9","author":"Y Tone","year":"2008","unstructured":"Tone Y, Furuuchi K, Kojima Y, Tykocinski ML, Greene MI, Tone M (2008) Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat Immunol 9:194\u2013202","journal-title":"Nat Immunol"},{"key":"407_CR54","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1182\/blood-2007-10-118539","volume":"111","author":"F Toulza","year":"2008","unstructured":"Toulza F, Heaps A, Tanaka Y, Taylor GP, Bangham CR (2008) High frequency of CD4+FoxP3+ cells in HTLV-1 infection: inverse correlation with HTLV-1-specific CTL response. Blood 111:5047\u201353","journal-title":"Blood"},{"key":"407_CR55","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1146\/annurev.immunol.15.1.15","volume":"15","author":"T Uchiyama","year":"1997","unstructured":"Uchiyama T (1997) Human T cell leukemia virus type I (HTLV-I) and human diseases. Annu Rev Immunol 15:15\u201337","journal-title":"Annu Rev Immunol"},{"key":"407_CR56","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/blood.V50.3.481.481","volume":"50","author":"T Uchiyama","year":"1977","unstructured":"Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H (1977) Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 50:481\u201392","journal-title":"Blood"},{"key":"407_CR57","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1742-4690-5-34","volume":"5","author":"T Usui","year":"2008","unstructured":"Usui T, Yanagihara K, Tsukasaki K, Murata K, Hasegawa H, Yamada Y, Kamihira S (2008) Characteristic expression of HTLV-1 basic zipper factor (HBZ) transcripts in HTLV-1 provirus-positive cells. Retrovirology 5:34","journal-title":"Retrovirology"},{"key":"407_CR58","doi-asserted-by":"crossref","first-page":"e1690","DOI":"10.1371\/journal.pntd.0001690","volume":"6","author":"C Tienen van","year":"2012","unstructured":"van Tienen C, de Silva TI, Alcantara LC, Onyango CO, Jarju S, Goncalves N, Vincent T, Aaby P, Whittle H, Schim van der Loeff M, Cotten M (2012) Molecular epidemiology of endemic human T-lymphotropic virus type 1 in a rural community in Guinea-Bissau. PLoS Negl Trop Dis 6:e1690","journal-title":"PLoS Negl Trop Dis"},{"key":"407_CR59","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S1473-3099(07)70081-6","volume":"7","author":"K Verdonck","year":"2007","unstructured":"Verdonck K, Gonzalez E, Van Dooren S, Vandamme AM, Vanham G, Gotuzzo E (2007) Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis 7:266\u201381","journal-title":"Lancet Infect Dis"},{"key":"407_CR60","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1172\/JCI19441","volume":"112","author":"MR Walker","year":"2003","unstructured":"Walker MR, Kasprowicz DJ, Gersuk VH, Benard A, Van Landeghen M, Buckner JH, Ziegler SF (2003) Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25\u2212 T cells. J Clin Invest 112:1437\u201343","journal-title":"J Clin Invest"},{"key":"407_CR61","doi-asserted-by":"crossref","first-page":"7994","DOI":"10.1073\/pnas.0501734102","volume":"102","author":"ND Wolfe","year":"2005","unstructured":"Wolfe ND, Heneine W, Carr JK, Garcia AD, Shanmugam V, Tamoufe U, Torimiro JN, Prosser AT, Lebreton M, Mpoudi-Ngole E, McCutchan FE, Birx DL, Folks TM, Burke DS, Switzer WM (2005) Emergence of unique primate T-lymphotropic viruses among central African bushmeat hunters. Proc Natl Acad Sci U S A 102:7994\u20139","journal-title":"Proc Natl Acad Sci U S A"},{"key":"407_CR62","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.canlet.2013.08.035","volume":"345","author":"C Xu","year":"2014","unstructured":"Xu C, Zhou W, Wang Y, Qiao L (2014) Hepatitis B virus-induced hepatocellular carcinoma. Cancer Lett 345:216\u201322","journal-title":"Cancer Lett"},{"key":"407_CR63","doi-asserted-by":"crossref","first-page":"e1003630","DOI":"10.1371\/journal.ppat.1003630","volume":"9","author":"N Yamamoto-Taguchi","year":"2013","unstructured":"Yamamoto-Taguchi N, Satou Y, Miyazato P, Ohshima K, Nakagawa M, Katagiri K, Kinashi T, Matsuoka M (2013) HTLV-1 bZIP factor induces inflammation through labile Foxp3 expression. PLoS Pathog 9:e1003630","journal-title":"PLoS Pathog"},{"key":"407_CR64","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1172\/JCI23913","volume":"115","author":"Y Yamano","year":"2005","unstructured":"Yamano Y, Takenouchi N, Li HC, Tomaru U, Yao K, Grant CW, Maric DA, Jacobson S (2005) Virus-induced dysfunction of CD4+CD25+ T cells in patients with HTLV-I-associated neuroimmunological disease. J Clin Invest 115:1361\u20138","journal-title":"J Clin Invest"},{"key":"407_CR65","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1097\/00002030-200307250-00011","volume":"17","author":"C Yang","year":"2003","unstructured":"Yang C, Li M, Newman RD, Shi YP, Ayisi J, van Eijk AM, Otieno J, Misore AO, Steketee RW, Nahlen BL, Lal RB (2003) Genetic diversity of HIV-1 in western Kenya: subtype-specific differences in mother-to-child transmission. AIDS 17:1667\u201374","journal-title":"AIDS"},{"key":"407_CR66","doi-asserted-by":"crossref","first-page":"9359","DOI":"10.1128\/JVI.00242-08","volume":"82","author":"M Yoshida","year":"2008","unstructured":"Yoshida M, Satou Y, Yasunaga J, Fujisawa J, Matsuoka M (2008) Transcriptional control of spliced and unspliced human T-cell leukemia virus type 1 bZIP factor (HBZ) gene. J Virol 82:9359\u201368","journal-title":"J Virol"},{"key":"407_CR67","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.leukres.2009.08.028","volume":"34","author":"J Zhang","year":"2010","unstructured":"Zhang J, Yamada O, Matsushita Y, Chagan-Yasutan H, Hattori T (2010) Transactivation of human osteopontin promoter by human T-cell leukemia virus type 1-encoded Tax protein. Leuk Res 34:763\u20138","journal-title":"Leuk Res"},{"key":"407_CR68","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1182\/blood-2010-12-326199","volume":"118","author":"T Zhao","year":"2011","unstructured":"Zhao T, Satou Y, Sugata K, Miyazato P, Green PL, Imamura T, Matsuoka M (2011) HTLV-1 bZIP factor enhances TGF-beta signaling through p300 coactivator. Blood 118:1865\u201376","journal-title":"Blood"}],"container-title":["Journal of NeuroVirology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-015-0407-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13365-015-0407-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-015-0407-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T04:13:21Z","timestamp":1653711201000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13365-015-0407-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,3]]},"references-count":68,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["407"],"URL":"https:\/\/doi.org\/10.1007\/s13365-015-0407-2","relation":{},"ISSN":["1355-0284","1538-2443"],"issn-type":[{"value":"1355-0284","type":"print"},{"value":"1538-2443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,3]]}}}